Calcification in aortic stenosis: The skeleton key

Journal of the American College of Cardiology

Volumn 66, Issue 5, 2015, Pages 561-577

  Pawade, Tania A ^a,b   Newby, David E ^a,b   Dweck, Marc R ^a,b,c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NHS LOTHIAN   (United Kingdom)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

aortic valve; calcification of; calcinosis; calcium; computed tomography; diphosphonates; positron emission tomography

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; AUTOTAXIN; BETA CATENIN; BISPHOSPHONIC ACID DERIVATIVE; BONE MORPHOGENETIC PROTEIN 2; DENOSUMAB; FETUIN A; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TRANSFORMING GROWTH FACTOR BETA1;

AGE DISTRIBUTION; AORTA DISEASE; AORTA STENOSIS; ATHEROSCLEROSIS; CALCIFICATION; CARDIOVASCULAR RISK; CELL SURVIVAL; CORONARY ARTERY CALCIUM SCORE; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG TOLERABILITY; ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; LIPID STORAGE; NONHUMAN; OSTEOBLAST; OXIDATIVE STRESS; PATHOGENESIS; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; UNSPECIFIED SIDE EFFECT; UPREGULATION; AORTA VALVE; AORTIC VALVE STENOSIS; CALCINOSIS; DISEASE MANAGEMENT; HEART VALVE REPLACEMENT; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; PROGNOSIS; SURGERY;

AORTIC VALVE; AORTIC VALVE STENOSIS; CALCINOSIS; DISEASE MANAGEMENT; DISEASE PROGRESSION; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PROGNOSIS;

EID: 84938085871     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.05.066     Document Type: Review

References (109)

1. V.T. Nkomo, J.M. Gardin, T.N. Skelton, and et al. Burden of valvular heart diseases: a population-based study Lancet 368 2006 1005 1011
2. R.L. Osnabrugge, D. Mylotte, S.J. Head, and et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study J Am Coll Cardiol 62 2013 1002 1012
3. N.M. Rajamannan, F.J. Evans, E. Aikawa, and et al. Calcific aortic valve disease: not simply a degenerative process. A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: calcific aortic valve disease - 2011 update Circulation 124 2011 1783 1791
4. S.E. New, and E. Aikawa Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification Circ Res 108 2011 1381 1391
5. G. Thanassoulis, J.M. Massaro, R. Cury, and et al. Associations of long-term and early adult atherosclerosis risk factors with aortic and mitral valve calcium J Am Coll Cardiol 55 2010 2491 2498
6. B.F. Stewart, D. Siscovick, B.K. Lind, and et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study J Am Coll Cardiol 29 1997 630 634
7. J. Stritzke, P. Linsel-Nitschke, M.R. Markus, and et al. Association between degenerative aortic valve disease and long-term exposure to cardiovascular risk factors: results of the longitudinal population-based KORA/MONICA survey Eur Heart J 30 2009 2044 2053
8. R.T. Pachulski, and K.L. Chan Progression of aortic valve dysfunction in 51 adult patients with congenital bicuspid aortic valve: assessment and follow up by Doppler echocardiography Br Heart J 69 1993 237 240
9. J.G. Smith, K. Luk, C.A. Schulz, et al. for the Cohorts for Heart and Aging Research in Genetic Epidemiology (CHARGE) Extracoronary Calcium Working Group Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis JAMA 312 2014 1764 1771
10. G. Thanassoulis, C.Y. Campbell, D.S. Owens, et al. for the CHARGE Extracoronary Calcium Working Group Genetic associations with valvular calcification and aortic stenosis N Engl J Med 368 2013 503 512
11. C.M. Otto, J. Kuusisto, D.D. Reichenbach, and et al. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies Circulation 90 1994 844 853
12. D. Proudfoot, J.N. Skepper, L. Hegyi, and et al. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies Circ Res 87 2000 1055 1062
13. K.M. Kim Calcification of matrix vesicles in human aortic valve and aortic media Fed Proc 35 1976 156 162
14. I. Nadra, J.C. Mason, P. Philippidis, and et al. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification? Circ Res 96 2005 1248 1256
15. L.M. Moura, S.F. Ramos, J.L. Zamorano, and et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis J Am Coll Cardiol 49 2007 554 561
16. N.M. Rajamannan, M. Subramaniam, M. Springett, and et al. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve Circulation 105 2002 2660 2665
17. R.M. Weiss, M. Ohashi, J.D. Miller, and et al. Calcific aortic valve stenosis in old hypercholesterolemic mice Circulation 114 2006 2065 2069
18. S.J. Cowell, D.E. Newby, R.J. Prescott, et al. for the Scottish Aortic Stenosis and Lipid Lowering Trial Impact on Regression (SALTIRE) Investigators A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis N Engl J Med 352 2005 2389 2397
19. K.L. Chan, K. Teo, J.G. Dumesnil, et al. for the ASTRONOMER Investigators Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial Circulation 121 2010 306 314
20. A.B. Rossebø, T.R. Pedersen, K. Boman, et al. for the SEAS Investigators Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis N Engl J Med 359 2008 1343 1356
21. R. Puri, S.J. Nicholls, M. Shao, and et al. Impact of statins on serial coronary calcification during atheroma progression and regression J Am Coll Cardiol 65 2015 1273 1282
22. R. Capoulade, M.A. Clavel, J.G. Dumesnil, et al. for the ASTRONOMER Investigators Impact of metabolic syndrome on progression of aortic stenosis: influence of age and statin therapy J Am Coll Cardiol 60 2012 216 223
23. E.R. Mohler 3rd, F. Gannon, C. Reynolds, and et al. Bone formation and inflammation in cardiac valves Circulation 103 2001 1522 1528
24. R.N. El Accaoui, S.T. Gould, G.P. Hajj, and et al. Aortic valve sclerosis in mice deficient in endothelial nitric oxide synthase Am J Physiol Heart Circ Physiol 306 2014 H1302 H1313
25. K.D. O'Brien, D.M. Shavelle, M.T. Caulfield, and et al. Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma Circulation 106 2002 2224 2230
26. T. Peltonen, J. Napankangas, P. Ohtonen, and et al. (Pro)renin receptors and angiotensin converting enzyme 2/angiotensin-(1-7)/Mas receptor axis in human aortic valve stenosis Atherosclerosis 216 2011 35 43
27. R. Capoulade, M.A. Clavel, P. Mathieu, and et al. Impact of hypertension and renin-angiotensin system inhibitors in aortic stenosis Eur J Clin Invest 43 2013 1262 1272
28. P. Ducy CBFA1: a molecular switch in osteoblast biology Dev Dyn 219 2000 461 471
29. N.M. Rajamannan, M. Subramaniam, D. Rickard, and et al. Human aortic valve calcification is associated with an osteoblast phenotype Circulation 107 2003 2181 2184
30. V. Pohjolainen, P. Taskinen, Y. Soini, and et al. Noncollagenous bone matrix proteins as a part of calcific aortic valve disease regulation Hum Pathol 39 2008 1695 1701
31. B. Ganss, R.H. Kim, and J. Sodek Bone sialoprotein Crit Rev Oral Biol Med 10 1999 79 98
32. A.C. Liu, V.R. Joag, and A.I. Gotlieb The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology Am J Pathol 171 2007 1407 1418
33. E. Aikawa, M. Nahrendorf, J.L. Figueiredo, and et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo Circulation 116 2007 2841 2850
34. E. Aikawa, and C.M. Otto Look more closely at the valve: imaging calcific aortic valve disease Circulation 125 2012 9 11
35. K.E. Watson, K. Bostrom, R. Ravindranath, and et al. TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify J Clin Invest 93 1994 2106 2113
36. Y. Tintut, and L. Demer Role of osteoprotegerin and its ligands and competing receptors in atherosclerotic calcification J Investig Med 54 2006 395 401
37. V. Garg, A.N. Muth, J.F. Ransom, and et al. Mutations in NOTCH1 cause aortic valve disease Nature 437 2005 270 274
38. V. Nigam, and D. Srivastava Notch1 represses osteogenic pathways in aortic valve cells J Mol Cell Cardiol 47 2009 828 834
39. K. Boström, K.E. Watson, W.P. Stanford, and et al. Atherosclerotic calcification: relation to developmental osteogenesis Am J Cardiol 75 1995 88B 91B
40. X. Yang, X. Meng, X. Su, and et al. Bone morphogenic protein 2 induces Runx2 and osteopontin expression in human aortic valve interstitial cells: role of Smad1 and extracellular signal-regulated kinase 1/2 J Thorac Cardiovasc Surg 138 2009 1008 1015
41. X. Yang, D.A. Fullerton, X. Su, and et al. Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2 J Am Coll Cardiol 53 2009 491 500
42. F.C. Caira, S.R. Stock, T.G. Gleason, and et al. Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation J Am Coll Cardiol 47 2006 1707 1712
43. J.H. Chen, W.L. Chen, K.L. Sider, and et al. β-catenin mediates mechanically regulated, transforming growth factor-β1-induced myofibroblast differentiation of aortic valve interstitial cells Arterioscl Thromb Vasc Biol 31 2011 590 597
44. -/- null mice J Cell Biochem 113 2012 1623 1634
45. D.M. Kado, W.S. Browner, T. Blackwell, and et al. Rate of bone loss is associated with mortality in older women: a prospective study J Bone Miner Res 15 2000 1974 1980
46. R. Pfister, G. Michels, S.J. Sharp, and et al. Inverse association between bone mineral density and risk of aortic stenosis in men and women in EPIC-Norfolk prospective study Int J Cardiol 178 2015 29 30
47. Y. Aksoy, C. Yagmur, G.O. Tekin, and et al. Aortic valve calcification: association with bone mineral density and cardiovascular risk factors Coron Artery Dis 16 2005 379 383
48. L.L. Demer, and Y. Tintut Vascular calcification: pathobiology of a multifaceted disease Circulation 117 2008 2938 2948
49. V. Persy, and P. D'Haese Vascular calcification and bone disease: the calcification paradox Trends Mol Med 15 2009 405 416
50. H.N. Hultgren Osteitis deformans (Paget's disease) and calcific disease of the heart valves Am J Cardiol 81 1998 1461 1464
51. J.J. Kaden, S. Bickelhaupt, R. Grobholz, and et al. Receptor activator of nuclear factor κB ligand and osteoprotegerin regulate aortic valve calcification J Mol Cell Cardiol 36 2004 57 66
52. N. Bucay, I. Sarosi, C.R. Dunstan, and et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification Genes Dev 12 1998 1260 1268
53. F. Parhami, A.D. Morrow, J. Balucan, and et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients Arterioscl Thromb Vasc Biol 17 1997 680 687
54. L.L. Demer Vascular calcification and osteoporosis: inflammatory responses to oxidized lipids Int J Epidemiol 31 2002 737 741
55. L.J. Schurgers, J. Uitto, and C.P. Reutelingsperger Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization Trends Mol Med 19 2013 217 226
56. E. Tantisattamo, K.H. Han, and W.C. O'Neill Increased vascular calcification in patients receiving warfarin Arterioscl Thromb Vasc Biol 35 2015 237 242
57. J.J. Kaden, J.O. Reinöhl, B. Blesch, and et al. Systemic and local levels of fetuin-A in calcific aortic valve stenosis Int J Mol Med 20 2007 193 197
58. R. Koos, V. Brandenburg, A.H. Mahnken, and et al. Association of fetuin-A levels with the progression of aortic valve calcification in non-dialyzed patients Eur Heart J 30 2009 2054 2061
59. D. Mohty, N. Côté, P. Pibarot, and et al. Reduced fetuin a serum level is associated with faster progression and increased valvular calcification in elderly patients with aortic stenosis J Clin Exp Cardiol 2 2011 147
60. R. Capoulade, N. Côté, P. Mathieu, et al. for the ASTRONOMER Investigators Circulating levels of matrix GLA protein and progression of aortic stenosis: a substudy of the Aortic Stenosis Progression Observation: Measuring Effects of rosuvastatin (ASTRONOMER) trial Can J Cardiol 30 2014 1088 1095
61. N. Côté, D. El Husseini, A. Pépin, and et al. ATP acts as a survival signal and prevents the mineralization of aortic valve J Mol Cell Cardiol 52 2012 1191 1202
62. D. El Husseini, M.C. Boulanger, A. Mahmut, and et al. P2Y2 receptor represses IL-6 expression by valve interstitial cells through Akt: implication for calcific aortic valve disease J Mol Cell Cardiol 72 2014 146 156
63. H. Baumgartner, J. Hung, J. Bermejo, and et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice Eur J Echocardiogr 22 2009 1 25
64. R. Rosenhek, T. Binder, G. Porenta, and et al. Predictors of outcome in severe, asymptomatic aortic stenosis N Engl J Med 343 2000 611 617
65. G. Cioffi, C. Mazzone, P. Faggiano, and et al. Prognostic stratification by conventional echocardiography of patients with aortic stenosis: the "CAIMAN-ECHO score." Echocardiography 30 2013 367 377
66. D. Messika-Zeitoun, M.C. Aubry, D. Detaint, and et al. Evaluation and clinical implications of aortic valve calcification measured by electron-beam computed tomography Circulation 110 2004 356 362
67. W. Jenkins, M. Dweck, A. Shah, and et al. 18F-NaF is a predictor of progression and outcome in aortic valve disease (abstr) J Am Coll Cardiol 63 Suppl 12 2014 A995
68. F. Liu, C.A. Coursey, C. Grahame-Clarke, and et al. Aortic valve calcification as an incidental finding at CT of the elderly: severity and location as predictors of aortic stenosis AJR Am J Roentgenol 186 2006 342 349
69. R. Koos, H.P. Kühl, G. Mühlenbruch, and et al. Prevalence and clinical importance of aortic valve calcification detected incidentally on CT scans: comparison with echocardiography Radiology 241 2006 76 82
70. S.R. Aggarwal, M.A. Clavel, D. Messika-Zeitoun, and et al. Sex differences in aortic valve calcification measured by multidetector computed tomography in aortic stenosis Circ Cardiovasc Imaging 6 2013 40 47
71. M.R. Dweck, C. Chin, and D.E. Newby Small valve area with low-gradient aortic stenosis: beware the hard hearted J Am Coll Cardiol 62 2013 2339 2340
72. M.A. Clavel, D. Messika-Zeitoun, P. Pibarot, and et al. The complex nature of discordant severe calcified aortic valve disease grading: new insights from combined Doppler echocardiographic and computed tomographic study J Am Coll Cardiol 62 2013 2329 2338
73. M.A. Clavel, P. Pibarot, D. Messika-Zeitoun, and et al. Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study J Am Coll Cardiol 64 2014 1202 1213
74. G.M. Feuchtner, S. Müller, W. Grander, and et al. Aortic valve calcification as quantified with multislice computed tomography predicts short-term clinical outcome in patients with asymptomatic aortic stenosis J Heart Valve Dis 15 2006 494 498
75. R. Koos, A.H. Mahnken, A.M. Sinha, and et al. Aortic valve calcification as a marker for aortic stenosis severity: assessment on 16-MDCT AJR Am J Roentgenol 183 2004 1813 1818
76. D. Messika-Zeitoun, L.F. Bielak, P.A. Peyser, and et al. Aortic valve calcification: determinants and progression in the population Arterioscl Thromb Vasc Biol 27 2007 642 648
77. M.R. Dweck, W.S. Jenkins, A.T. Vesey, and et al. 18F-NaF uptake is a marker of active calcification and disease progression in patients with aortic stenosis Circ Cardiovasc Imaging 7 2014 371 378
78. V. Nguyen, C. Cimadevilla, C. Estellat, and et al. Haemodynamic and anatomic progression of aortic stenosis Heart 101 2015 943 947
79. M.R. Dweck, C. Jones, N.V. Joshi, and et al. Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis Circulation 125 2012 76 86
80. G. Marincheva-Savcheva, S. Subramanian, S. Qadir, and et al. Imaging of the aortic valve using fluorodeoxyglucose positron emission tomography: increased valvular fluorodeoxyglucose uptake in aortic stenosis J Am Coll Cardiol 57 2011 2507 2515
81. M.R. Dweck, H.J. Khaw, G.K. Sng, and et al. Aortic stenosis, atherosclerosis, and skeletal bone: is there a common link with calcification and inflammation? Eur Heart J 34 2013 1567 1574
82. N. Tahara, H. Kai, H. Nakaura, and et al. The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose-positron emission tomography Eur Heart J 28 2007 2243 2248
83. 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients J Am Coll Cardiol 48 2006 1818 1824
84. N. Tahara, H. Kai, M. Ishibashi, and et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography J Am Coll Cardiol 48 2006 1825 1831
85. A. Irkle, A.T. Vesey, D.Y. Lewis, and et al. Identifying active vascular micro-calcification by 18F-sodium fluoride positron emission tomography Nat Commun 6 2015 7495
86. C.M. Otto Calcific aortic stenosis - time to look more closely at the valve N Engl J Med 359 2008 1395 1398
87. P.A. Price, S.A. Faus, and M.K. Williamson Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption Arterioscl Thromb Vasc Biol 21 2001 817 824
88. H. Fleisch, R.G. Russell, and M.D. Francis Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo Science 165 1969 1262 1264
89. I.Y. Rosenblum, L. Flora, and R. Eisenstein The effect of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on a rabbit model of athero-arteriosclerosis Atherosclerosis 22 1975 411 424
90. D.M. Kramsch, and C.T. Chan The effect of agents interfering with soft tissue calcification and cell proliferation on calcific fibrous-fatty plaques in rabbits Circ Res 42 1978 562 571
91. P. Sansoni, G. Passeri, F. Fagnoni, and et al. Inhibition of antigen-presenting cell function by alendronate in vitro J Bone Miner Res 10 1995 1719 1725
92. E. Giraudo, M. Inoue, and D. Hanahan An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis J Clin Invest 114 2004 623 633
93. T.J. Lai, S.F. Hsu, T.M. Li, and et al. Alendronate inhibits cell invasion and MMP-2 secretion in human chondrosarcoma cell line Acta Pharmacologica Sinica 28 2007 1231 1235
94. S. Elmariah, G. Cimmino, V. Fuster, and et al. Bisphosphonates prevent oxidized low- density lipoprotein-induced expression of osteogenic markers in aortic valve myofibroblasts (abstr) J Am Coll Cardiol 55 Suppl 10A 2010 A149
95. S. Elmariah, J.A.C. Delaney, K.D. O'Brien, and et al. Bisphosphonate use and prevalence of valvular and vascular calcification in women: MESA (The Multi-Ethnic Study of Atherosclerosis) J Am Coll Cardiol 56 2010 1752 1759
96. A.L. Innasimuthu, and W.E. Katz Effect of bisphosphonates on the progression of degenerative aortic stenosis Echocardiography 28 2011 1 7
97. A.H. Skolnick, M. Osranek, P. Formica, and et al. Osteoporosis treatment and progression of aortic stenosis Am J Cardiol 104 2009 122 124
98. G. Sterbakova, V. Vyskocil, and K. Linhartova Bisphosphonates in calcific aortic stenosis: association with slower progression in mild disease-a pilot retrospective study Cardiology 117 2010 184 189
99. H.S. Rapoport, J.M. Connolly, J. Fulmer, and et al. Mechanisms of the in vivo inhibition of calcification of bioprosthetic porcine aortic valve cusps and aortic wall with triglycidylamine/mercapto bisphosphonate Biomaterials 28 2007 690 699
100. O. Aksoy, A. Cam, S.S. Goel, and et al. Do bisphosphonates slow the progression of aortic stenosis? J Am Coll Cardiol 59 2012 1452 1459
101. M.R. Dweck, and D.E. Newby Osteoporosis is a major confounder in observational studies investigating bisphosphonate therapy in aortic stenosis J Am Coll Cardiol 60 2012 1027
102. S.R. Cummings, J. San Martin, M.R. McClung, et al. for the FREEDOM Trial Denosumab for prevention of fractures in postmenopausal women with osteoporosis N Engl J Med 361 2009 756 765
103. S. Helas, C. Goettsch, M. Schoppet, and et al. Inhibition of receptor activator of NF-κB ligand by denosumab attenuates vascular calcium deposition in mice Am J Pathol 175 2009 473 478
104. University of Edinburgh. Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis (SALTIRE II). 2014. Available at: https://clinicaltrials.gov/ct2/show/NCT02132026. Accessed May 27, 2015.
105. N. Côté, D. El Husseini, A. Pépin, and et al. Inhibition of ectonucleotidase with ARL67156 prevents the development of calcific aortic valve disease in warfarin-treated rats Eur J Pharmacol 689 2012 139 146
106. M.Y. Hung, and S. Tsimikas What is the ultimate test that lowering lipoprotein(a) is beneficial for cardiovascular disease and aortic stenosis? Curr Opin Lipidol 25 2014 423 430
107. S.J. Cowell, D.E. Newby, J. Burton, and et al. Aortic valve calcification on computed tomography predicts the severity of aortic stenosis Clin Radiol 58 2003 712 716
108. C. Cueff, J.M. Serfaty, C. Cimadevilla, and et al. Measurement of aortic valve calcification using multislice computed tomography: correlation with haemodynamic severity of aortic stenosis and clinical implication for patients with low ejection fraction Heart 97 2011 721 726
109. H. Utsunomiya, H. Yamamoto, T. Kitagawa, and et al. Incremental prognostic value of cardiac computed tomography angiography in asymptomatic aortic stenosis: significance of aortic valve calcium score Int J Cardiol 168 2013 5205 5211